Evaluation of clinical and immunogenetic risk factors for the development of hepatotoxicity during antituberculosis treatment.

Sharma, Surendra K

Evaluation of clinical and immunogenetic risk factors for the development of hepatotoxicity during antituberculosis treatment. [electronic resource] - American journal of respiratory and critical care medicine Oct 2002 - 916-9 p. digital

Publication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

1073-449X

10.1164/rccm.2108091 doi


Adolescent
Adult
Aged
Aged, 80 and over
Alleles
Antitubercular Agents--adverse effects
Chemical and Drug Induced Liver Injury--epidemiology
Female
Follow-Up Studies
Genetic Predisposition to Disease
HLA-DQ Antigens--genetics
HLA-DR Antigens--genetics
Haplotypes
Humans
Immunogenetics
India--epidemiology
Male
Middle Aged
Multivariate Analysis
Risk Factors
Serum Albumin--metabolism
Tuberculosis, Pulmonary--complications